 Robert Kowalski
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 9 | 2023 | 360 | 2.460 |
Why?
| | Brain Ischemia | 4 | 2025 | 338 | 1.790 |
Why?
| | Subarachnoid Hemorrhage | 14 | 2015 | 66 | 1.580 |
Why?
| | Consciousness | 4 | 2022 | 27 | 1.550 |
Why?
| | Brain Injuries | 7 | 2023 | 494 | 1.360 |
Why?
| | Stroke | 6 | 2023 | 1120 | 1.030 |
Why?
| | Interleukin-6 | 2 | 2025 | 778 | 0.850 |
Why?
| | Glasgow Coma Scale | 6 | 2016 | 186 | 0.790 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 65 | 0.760 |
Why?
| | Recovery of Function | 4 | 2021 | 653 | 0.740 |
Why?
| | Hospital Mortality | 6 | 2015 | 911 | 0.720 |
Why?
| | Neurological Rehabilitation | 1 | 2021 | 9 | 0.710 |
Why?
| | Music Therapy | 1 | 2021 | 25 | 0.690 |
Why?
| | Acoustic Stimulation | 1 | 2021 | 312 | 0.630 |
Why?
| | Gait | 1 | 2021 | 296 | 0.560 |
Why?
| | Status Epilepticus | 2 | 2020 | 50 | 0.540 |
Why?
| | Intracranial Aneurysm | 3 | 2015 | 97 | 0.520 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 2016 | 30 | 0.510 |
Why?
| | Exercise Therapy | 1 | 2021 | 443 | 0.510 |
Why?
| | Prognosis | 10 | 2023 | 4030 | 0.490 |
Why?
| | Coma | 2 | 2015 | 32 | 0.480 |
Why?
| | Hydrocephalus | 1 | 2016 | 106 | 0.470 |
Why?
| | Consciousness Disorders | 4 | 2023 | 20 | 0.430 |
Why?
| | Wakefulness | 1 | 2015 | 125 | 0.430 |
Why?
| | Aged | 26 | 2025 | 23961 | 0.420 |
Why?
| | Middle Aged | 31 | 2025 | 33479 | 0.420 |
Why?
| | Life Support Care | 1 | 2013 | 33 | 0.420 |
Why?
| | Pentobarbital | 2 | 2012 | 16 | 0.410 |
Why?
| | Tomography, X-Ray Computed | 6 | 2019 | 2691 | 0.410 |
Why?
| | Severity of Illness Index | 3 | 2017 | 2828 | 0.380 |
Why?
| | Vasoconstrictor Agents | 1 | 2012 | 139 | 0.370 |
Why?
| | Brain Edema | 1 | 2011 | 61 | 0.350 |
Why?
| | Anticonvulsants | 2 | 2012 | 217 | 0.340 |
Why?
| | Aged, 80 and over | 9 | 2025 | 7635 | 0.340 |
Why?
| | Adult | 27 | 2023 | 37929 | 0.340 |
Why?
| | Male | 36 | 2025 | 67762 | 0.330 |
Why?
| | Predictive Value of Tests | 11 | 2023 | 2031 | 0.330 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 224 | 0.320 |
Why?
| | Female | 37 | 2025 | 73304 | 0.320 |
Why?
| | Intensive Care Units | 6 | 2020 | 827 | 0.310 |
Why?
| | Rehabilitation Centers | 2 | 2021 | 39 | 0.300 |
Why?
| | Mobile Health Units | 2 | 2019 | 21 | 0.300 |
Why?
| | Brain | 3 | 2019 | 2668 | 0.290 |
Why?
| | Respiration, Artificial | 1 | 2012 | 645 | 0.280 |
Why?
| | Cohort Studies | 9 | 2021 | 5742 | 0.280 |
Why?
| | Humans | 46 | 2025 | 137585 | 0.270 |
Why?
| | Heart Arrest | 1 | 2011 | 339 | 0.270 |
Why?
| | Pulmonary Embolism | 2 | 2020 | 226 | 0.270 |
Why?
| | Treatment Outcome | 9 | 2023 | 10811 | 0.260 |
Why?
| | Venous Thromboembolism | 2 | 2020 | 316 | 0.240 |
Why?
| | Disability Evaluation | 4 | 2022 | 290 | 0.230 |
Why?
| | Patient Discharge | 3 | 2021 | 897 | 0.230 |
Why?
| | Cocaine-Related Disorders | 3 | 2015 | 113 | 0.210 |
Why?
| | Incidence | 5 | 2017 | 2804 | 0.210 |
Why?
| | Hospitalization | 3 | 2021 | 2199 | 0.210 |
Why?
| | Age Factors | 8 | 2019 | 3295 | 0.200 |
Why?
| | Critical Illness | 4 | 2020 | 811 | 0.200 |
Why?
| | Diagnostic Errors | 1 | 2004 | 170 | 0.200 |
Why?
| | Prospective Studies | 8 | 2017 | 7604 | 0.190 |
Why?
| | Databases, Factual | 3 | 2017 | 1357 | 0.190 |
Why?
| | Critical Care | 4 | 2015 | 601 | 0.190 |
Why?
| | Time Factors | 4 | 2025 | 6828 | 0.190 |
Why?
| | Retrospective Studies | 13 | 2020 | 15657 | 0.180 |
Why?
| | Seizures | 3 | 2020 | 426 | 0.170 |
Why?
| | Fever | 3 | 2007 | 306 | 0.170 |
Why?
| | Retinal Artery Occlusion | 1 | 2020 | 9 | 0.170 |
Why?
| | Product Labeling | 1 | 2020 | 10 | 0.170 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1946 | 0.170 |
Why?
| | Health Care Sector | 1 | 2020 | 25 | 0.170 |
Why?
| | Spinal Cord Injuries | 2 | 2016 | 212 | 0.170 |
Why?
| | Physical Therapy Modalities | 2 | 2021 | 308 | 0.170 |
Why?
| | Drug Labeling | 1 | 2020 | 39 | 0.170 |
Why?
| | Health Information Exchange | 1 | 2020 | 23 | 0.160 |
Why?
| | Return to Work | 1 | 2020 | 21 | 0.160 |
Why?
| | Posture | 1 | 2021 | 185 | 0.160 |
Why?
| | Access to Information | 1 | 2020 | 49 | 0.160 |
Why?
| | Time-to-Treatment | 2 | 2019 | 205 | 0.160 |
Why?
| | Teleradiology | 1 | 2019 | 5 | 0.160 |
Why?
| | Wireless Technology | 1 | 2019 | 13 | 0.160 |
Why?
| | Young Adult | 5 | 2021 | 13209 | 0.160 |
Why?
| | Systems Integration | 1 | 2019 | 37 | 0.160 |
Why?
| | Ambulances | 1 | 2019 | 51 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 146 | 0.150 |
Why?
| | Fibrinolysis | 1 | 2020 | 146 | 0.150 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2019 | 89 | 0.150 |
Why?
| | Postural Balance | 1 | 2021 | 215 | 0.140 |
Why?
| | Epilepsy | 2 | 2020 | 333 | 0.140 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 270 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2013 | 1509 | 0.140 |
Why?
| | Neuroimaging | 2 | 2019 | 259 | 0.130 |
Why?
| | Amnesia | 1 | 2016 | 43 | 0.130 |
Why?
| | Risk Factors | 13 | 2020 | 10388 | 0.130 |
Why?
| | Acute Disease | 3 | 2015 | 1007 | 0.130 |
Why?
| | Walking | 1 | 2021 | 529 | 0.120 |
Why?
| | Body Temperature | 2 | 2007 | 222 | 0.120 |
Why?
| | Adolescent | 4 | 2021 | 21513 | 0.120 |
Why?
| | Pilot Projects | 1 | 2021 | 1710 | 0.120 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2015 | 53 | 0.110 |
Why?
| | Aneurysm, Ruptured | 2 | 2013 | 35 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 44 | 0.110 |
Why?
| | APACHE | 2 | 2012 | 69 | 0.110 |
Why?
| | Cold Temperature | 1 | 2015 | 179 | 0.110 |
Why?
| | Biomarkers | 1 | 2025 | 4149 | 0.110 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 255 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 547 | 0.100 |
Why?
| | Hospitals, Special | 1 | 2012 | 9 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 2015 | 266 | 0.100 |
Why?
| | Electroencephalography | 3 | 2020 | 423 | 0.100 |
Why?
| | Cognition Disorders | 2 | 2014 | 496 | 0.090 |
Why?
| | Patient Admission | 1 | 2013 | 197 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2012 | 329 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1069 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2012 | 1316 | 0.090 |
Why?
| | Length of Stay | 1 | 2016 | 1215 | 0.090 |
Why?
| | Emergency Service, Hospital | 2 | 2012 | 2069 | 0.090 |
Why?
| | Comorbidity | 5 | 2015 | 1622 | 0.080 |
Why?
| | Nerve Compression Syndromes | 1 | 2009 | 21 | 0.080 |
Why?
| | Patient Transfer | 1 | 2012 | 176 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 692 | 0.080 |
Why?
| | Neural Conduction | 1 | 2009 | 86 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2013 | 421 | 0.080 |
Why?
| | Academic Medical Centers | 1 | 2012 | 512 | 0.080 |
Why?
| | Perioperative Care | 1 | 2011 | 178 | 0.080 |
Why?
| | Survival Analysis | 1 | 2012 | 1325 | 0.080 |
Why?
| | Arm | 1 | 2009 | 104 | 0.080 |
Why?
| | Health Status Indicators | 2 | 2012 | 171 | 0.070 |
Why?
| | Thrombolytic Therapy | 2 | 2020 | 142 | 0.070 |
Why?
| | Registries | 1 | 2016 | 2035 | 0.070 |
Why?
| | Risk Assessment | 3 | 2013 | 3457 | 0.070 |
Why?
| | Monitoring, Intraoperative | 1 | 2008 | 56 | 0.070 |
Why?
| | Inpatients | 3 | 2020 | 500 | 0.070 |
Why?
| | Hypothermia, Induced | 2 | 2007 | 80 | 0.070 |
Why?
| | Propofol | 1 | 2008 | 73 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5131 | 0.070 |
Why?
| | Shivering | 1 | 2007 | 5 | 0.070 |
Why?
| | Conscious Sedation | 1 | 2008 | 92 | 0.070 |
Why?
| | Cryotherapy | 1 | 2007 | 17 | 0.070 |
Why?
| | Cerebral Infarction | 1 | 2007 | 44 | 0.070 |
Why?
| | Glasgow Outcome Scale | 2 | 2019 | 10 | 0.060 |
Why?
| | Logistic Models | 3 | 2020 | 2074 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2004 | 56 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 275 | 0.050 |
Why?
| | Blood Pressure | 1 | 2009 | 1786 | 0.050 |
Why?
| | Government Regulation | 1 | 2020 | 54 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 155 | 0.040 |
Why?
| | Policy Making | 1 | 2020 | 98 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2020 | 99 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1295 | 0.040 |
Why?
| | Smoking Cessation | 1 | 2003 | 442 | 0.040 |
Why?
| | Hot Temperature | 2 | 2015 | 391 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 530 | 0.040 |
Why?
| | Workflow | 1 | 2019 | 165 | 0.040 |
Why?
| | ROC Curve | 2 | 2013 | 554 | 0.030 |
Why?
| | Odds Ratio | 2 | 2015 | 1070 | 0.030 |
Why?
| | United States | 3 | 2020 | 14841 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2019 | 522 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 261 | 0.030 |
Why?
| | Mid-Atlantic Region | 1 | 2015 | 5 | 0.030 |
Why?
| | Smoking | 1 | 2003 | 1627 | 0.030 |
Why?
| | Culture | 1 | 2016 | 128 | 0.030 |
Why?
| | Politics | 1 | 2016 | 98 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 898 | 0.030 |
Why?
| | Drug Monitoring | 2 | 2008 | 218 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 773 | 0.030 |
Why?
| | Anticoagulants | 1 | 2019 | 664 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3556 | 0.030 |
Why?
| | Data Collection | 1 | 2016 | 673 | 0.030 |
Why?
| | Residence Characteristics | 1 | 2016 | 351 | 0.030 |
Why?
| | Area Under Curve | 1 | 2013 | 314 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2844 | 0.020 |
Why?
| | Sex Factors | 2 | 2009 | 2071 | 0.020 |
Why?
| | Educational Status | 1 | 2014 | 470 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1289 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 271 | 0.020 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2009 | 27 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4565 | 0.020 |
Why?
| | Weights and Measures | 1 | 2008 | 8 | 0.020 |
Why?
| | Neurophysiology | 1 | 2008 | 12 | 0.020 |
Why?
| | Entropy | 1 | 2008 | 41 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2008 | 47 | 0.020 |
Why?
| | Judgment | 1 | 2008 | 60 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 103 | 0.020 |
Why?
| | Clinical Competence | 1 | 2015 | 1118 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2008 | 413 | 0.020 |
Why?
| | Energy Transfer | 1 | 2007 | 46 | 0.020 |
Why?
| | Lateral Ventricles | 1 | 2007 | 35 | 0.020 |
Why?
| | Automation | 1 | 2007 | 95 | 0.020 |
Why?
| | Hyponatremia | 1 | 2007 | 42 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 67 | 0.020 |
Why?
| | Magnesium | 1 | 2007 | 156 | 0.020 |
Why?
| | Cerebral Hemorrhage | 1 | 2007 | 108 | 0.020 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 125 | 0.010 |
Why?
| | Equipment Safety | 1 | 2004 | 37 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 494 | 0.010 |
Why?
| | Radiography | 1 | 2007 | 822 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 849 | 0.010 |
Why?
| | Observation | 1 | 2004 | 50 | 0.010 |
Why?
| | Acetaminophen | 1 | 2007 | 268 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 282 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2011 | 758 | 0.010 |
Why?
| | Probability | 1 | 2004 | 304 | 0.010 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 97 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 431 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2057 | 0.010 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2004 | 93 | 0.010 |
Why?
| | New York | 1 | 2003 | 126 | 0.010 |
Why?
| | Brain Diseases | 1 | 2004 | 141 | 0.010 |
Why?
| | Equipment Design | 1 | 2004 | 522 | 0.010 |
Why?
| | Heart Rate | 1 | 2007 | 822 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1024 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1060 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2003 | 828 | 0.010 |
Why?
| | Depression | 1 | 2003 | 1397 | 0.010 |
Why?
| | Infant | 1 | 2004 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2004 | 11074 | 0.000 |
Why?
| | Child | 1 | 2004 | 21935 | 0.000 |
Why?
|
|
Kowalski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|